Genomics

Dataset Information

Cisplatin resistance driver gene CLSPN product is a target for immunotherapy in urothelial carcinoma.


ABSTRACT: Cisplatin resistance driver gene CLSPN product is a target for immunotherapy in urothelial carcinoma.

PROVIDER: PRJNA898969 | ENA |

REPOSITORIES: ENA